Show simple item record

dc.contributor.authorMacklin-Doherty, A
dc.contributor.authorJones, M
dc.contributor.authorCoulson, P
dc.contributor.authorBruce, C
dc.contributor.authorChau, I
dc.contributor.authorAlexander, E
dc.contributor.authorIyengar, S
dc.contributor.authorTaj, M
dc.contributor.authorCunningham, D
dc.contributor.authorSwerdlow, A
dc.date.accessioned2022-02-01T16:17:54Z
dc.date.available2022-02-01T16:17:54Z
dc.date.issued2022-02-23
dc.identifier.citationLeukemia & lymphoma, 2021, pp. 1 - 11
dc.identifier.issn1042-8194
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4992
dc.identifier.eissn1029-2403
dc.identifier.eissn1029-2403
dc.identifier.doi10.1080/10428194.2021.1999445
dc.identifier.doi10.1080/10428194.2021.1999445
dc.description.abstractThyroid abnormalities are well reported following childhood treatment for Hodgkin Lymphoma (HL). Limited information exists for adult patients and after modern treatments. We analyzed risks of thyroid disorders in 237 female participants treated at the Royal Marsden Hospital 1970-2015. Multivariable analyses of risk according to treatment and time-related factors, survival analyses, and Cox regression modeling were undertaken. Overall, 33.8% of patients reported thyroid disorders (hypothyroidism 30.0% and thyroid nodules 6.8%). Cumulative prevalence was 42.9% by 40 years follow-up. Risks were greatest after supradiaphragmatic radiotherapy (RR = 5.0, p < 0.001), and increasing dose (RR = 1.03/Gy, p < 0.001). There was no association with a chemotherapy agent. Risks of thyroid disease were as raised following adult as childhood treatment. There was no trend in risk by decade of supradiaphragmatic radiotherapy treatment. Risks of thyroid disease after supradiaphragmatic radiotherapy are as great after adult as childhood treatment and persist after more recent treatment periods.
dc.formatPrint-Electronic
dc.format.extent1 - 11
dc.languageeng
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleRisk of thyroid disorders in adult and childhood Hodgkin lymphoma survivors 40 years after treatment.
dc.typeJournal Article
dcterms.dateAccepted2021-10-24
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1080/10428194.2021.1999445
rioxxterms.licenseref.startdate2021-11-05
dc.relation.isPartOfLeukemia & lymphoma
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Aetiological Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Aetiological Epidemiology
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/15/16 Starting Cohort
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamMedicine (RMH Smith Cunningham)
icr.researchteamAetiological Epidemiology
dc.contributor.icrauthorMacklin-Doherty, Aislinn
dc.contributor.icrauthorJones, Michael


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/